Kriya closes $270 million Series C financing
Kriya Therapeutics is an American gene therapy developer focused on targeting serious chronic diseases affecting millions of patients, aiming to expand the therapeutic field of gene therapy beyond rare monogenic diseases. It enables the rational design of one-off gene therapies for the durable expression of therapeutic proteins in suitable human tissues by gaining a deep […]
Kriya closes $270 million Series C financing Read More »